215 related articles for article (PubMed ID: 2436132)
21. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
Bonadonna G
Cancer Res; 1982 Nov; 42(11):4309-20. PubMed ID: 6181867
[TBL] [Abstract][Full Text] [Related]
23. ABVD chemotherapy of Hodgkin's disease.
Molnár Z; Schneider T; Várady E; Fleischmann T
Neoplasma; 1997; 44(4):263-5. PubMed ID: 9473781
[TBL] [Abstract][Full Text] [Related]
24. Corticosteroid drugs: their role in oncological practice.
Lowenthal RM; Jestrimski KW
Med J Aust; 1986 Jan; 144(2):81-5. PubMed ID: 2417096
[No Abstract] [Full Text] [Related]
25. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
26. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
27. Hodgkin's disease in Indian children: outcome with chemotherapy alone.
Arya LS; Dinand V; Thavaraj V; Bakhshi S; Dawar R; Rath GK; Singh R; Vats TS
Pediatr Blood Cancer; 2006 Jan; 46(1):26-34. PubMed ID: 16161019
[TBL] [Abstract][Full Text] [Related]
28. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
29. [Primary treatment of advanced Hodgkin's disease].
Illés A; Udvardy M; Molnár Z
Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586
[TBL] [Abstract][Full Text] [Related]
30. European experience with ifosfamide in lymphomas.
von Kalle AK; Schaadt M; Diehl V
Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
[TBL] [Abstract][Full Text] [Related]
31. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
[TBL] [Abstract][Full Text] [Related]
32. [Results of cytostatic polychemotherapy in non-Hodgkin lymphomas].
Kratzer H; Hehenwarter W; Denz H; Bliem J; Tschurtschenthaler G; Nitsche D; Huber H; Michlmayr G
Wien Klin Wochenschr; 1983 Aug; 95(16):558-62. PubMed ID: 6689099
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of malignant lymphoma in childhood].
Hattori T; Ishikawa Y; Nishi M; Nakadate H; Hatae Y; Takeda T
Rinsho Ketsueki; 1985 Jan; 26(1):1-6. PubMed ID: 2582160
[No Abstract] [Full Text] [Related]
34. Influence of chemotherapy on the phagocytic activity of mononuclear cells in patients with Hodgkin's disease.
Süss J; Bakács T; Molnár Z
Allerg Immunol (Leipz); 1984; 30(4):251-4. PubMed ID: 6084424
[TBL] [Abstract][Full Text] [Related]
35. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
Lipton JH; Gospodarowicz M; Reingold S
Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
[TBL] [Abstract][Full Text] [Related]
37. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
[TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
[TBL] [Abstract][Full Text] [Related]
39. [Drug therapy of malignant lymphoma].
Ogawa M; Inagaki J
Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
[No Abstract] [Full Text] [Related]
40. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
Canellos GP; Duggan D; Johnson J; Niedzwiecki D
J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
